Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder

Markku Lähteenvuo(University of Eastern Finland), Heidi Taipale(Niuvanniemi Hospital), Anssi Solismaa(Tampere University), Ellenor Mittendorfer‐Rutz(Karolinska Institutet), Jari Tiihonen(University of Eastern Finland), Antti O. Tanskanen(University of Eastern Finland)

JAMA Psychiatry

November 13, 2024

10.1001/jamapsychiatry.2024.3599

Cited by 105

Related Papers

Suicide trends in the early months of the COVID-19 pandemic: an interrupted time-series analysis of preliminary data from 21 countries

|The Lancet Psychiatry|2021|742

Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors

|World Psychiatry|2022|624

Vascular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endothelial Growth Factor Receptor-1– and Neuropilin Receptor-1–Dependent Mechanisms

|Circulation|2009|195

Growth Factor Therapy and Autologous Lymph Node Transfer in Lymphedema

|Circulation|2011|181

Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder

|JAMA Psychiatry|2018|147